FR2837099B1 - COMPOSITION WITH GELIFYING PROPERTIES FOR PROLONGED DELIVERY OF BIO-ACTIVE SUBSTANCES - Google Patents

COMPOSITION WITH GELIFYING PROPERTIES FOR PROLONGED DELIVERY OF BIO-ACTIVE SUBSTANCES

Info

Publication number
FR2837099B1
FR2837099B1 FR0203059A FR0203059A FR2837099B1 FR 2837099 B1 FR2837099 B1 FR 2837099B1 FR 0203059 A FR0203059 A FR 0203059A FR 0203059 A FR0203059 A FR 0203059A FR 2837099 B1 FR2837099 B1 FR 2837099B1
Authority
FR
France
Prior art keywords
bio
composition
active substances
prolonged delivery
gelifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0203059A
Other languages
French (fr)
Other versions
FR2837099A1 (en
Inventor
Jean Christophe Leroux
Hoarau Anne Claude Couffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0203059A priority Critical patent/FR2837099B1/en
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Priority to ES03725281.4T priority patent/ES2607980T3/en
Priority to NZ535270A priority patent/NZ535270A/en
Priority to MXPA04008906A priority patent/MXPA04008906A/en
Priority to PCT/FR2003/000797 priority patent/WO2003075885A1/en
Priority to US10/507,281 priority patent/US7691408B2/en
Priority to CA2478825A priority patent/CA2478825C/en
Priority to KR1020047014388A priority patent/KR100906547B1/en
Priority to AU2003227827A priority patent/AU2003227827B2/en
Priority to CN03810055A priority patent/CN100584314C/en
Priority to BRPI0308360A priority patent/BRPI0308360B8/en
Priority to JP2003574161A priority patent/JP2005528352A/en
Priority to EP03725281.4A priority patent/EP1485066B1/en
Publication of FR2837099A1 publication Critical patent/FR2837099A1/en
Priority to IL164031A priority patent/IL164031A/en
Priority to ZA200407316A priority patent/ZA200407316B/en
Priority to NO20044310A priority patent/NO339426B1/en
Application granted granted Critical
Publication of FR2837099B1 publication Critical patent/FR2837099B1/en
Priority to HK05104957.8A priority patent/HK1071704A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0203059A 2002-03-12 2002-03-12 COMPOSITION WITH GELIFYING PROPERTIES FOR PROLONGED DELIVERY OF BIO-ACTIVE SUBSTANCES Expired - Fee Related FR2837099B1 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
FR0203059A FR2837099B1 (en) 2002-03-12 2002-03-12 COMPOSITION WITH GELIFYING PROPERTIES FOR PROLONGED DELIVERY OF BIO-ACTIVE SUBSTANCES
EP03725281.4A EP1485066B1 (en) 2002-03-12 2003-03-12 Composition having gelling properties for the prolonged delivery of bioactive substances
MXPA04008906A MXPA04008906A (en) 2002-03-12 2003-03-12 Composition having gelling properties for the prolonged delivery of bioactive substances.
PCT/FR2003/000797 WO2003075885A1 (en) 2002-03-12 2003-03-12 Composition having gelling properties for the prolonged delivery of bioactive substances
US10/507,281 US7691408B2 (en) 2002-03-12 2003-03-12 Composition having gelling properties for the prolonged delivery of bioactive substances
CA2478825A CA2478825C (en) 2002-03-12 2003-03-12 Composition having gelling properties for the prolonged delivery of bioactive substances
KR1020047014388A KR100906547B1 (en) 2002-03-12 2003-03-12 Composition having gelling properties for the prolonged delivery of bioactive substances
AU2003227827A AU2003227827B2 (en) 2002-03-12 2003-03-12 Composition having gelling properties for the prolonged delivery of bioactive substances
ES03725281.4T ES2607980T3 (en) 2002-03-12 2003-03-12 Composition with gelling properties intended for the prolonged supply of bioactive substances
BRPI0308360A BRPI0308360B8 (en) 2002-03-12 2003-03-12 thermosensitive composition in liquid form comprising organogelling substance, use of a composition and process for preparing a composition
JP2003574161A JP2005528352A (en) 2002-03-12 2003-03-12 Composition with gelling properties for use in sustained release of bioactive substances
NZ535270A NZ535270A (en) 2002-03-12 2003-03-12 Composition having gelling properties for the sustained delivery of bioactive substances
CN03810055A CN100584314C (en) 2002-03-12 2003-03-12 Composition having gelling properties for the prolonged delivery of bioactive substances
IL164031A IL164031A (en) 2002-03-12 2004-09-12 Compositiion having gelling properaties for the prolonged delivery of bioactive substances
ZA200407316A ZA200407316B (en) 2002-03-12 2004-09-13 Composition having gelling properties for the prolonged delivery of bioactive substances.
NO20044310A NO339426B1 (en) 2002-03-12 2004-10-12 Composition having gelling properties for delayed delivery of bioactive substances
HK05104957.8A HK1071704A1 (en) 2002-03-12 2005-06-14 Composition having gelling properties for the prolonged delivery of bioactive substances []

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0203059A FR2837099B1 (en) 2002-03-12 2002-03-12 COMPOSITION WITH GELIFYING PROPERTIES FOR PROLONGED DELIVERY OF BIO-ACTIVE SUBSTANCES

Publications (2)

Publication Number Publication Date
FR2837099A1 FR2837099A1 (en) 2003-09-19
FR2837099B1 true FR2837099B1 (en) 2005-03-18

Family

ID=27772051

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0203059A Expired - Fee Related FR2837099B1 (en) 2002-03-12 2002-03-12 COMPOSITION WITH GELIFYING PROPERTIES FOR PROLONGED DELIVERY OF BIO-ACTIVE SUBSTANCES

Country Status (3)

Country Link
ES (1) ES2607980T3 (en)
FR (1) FR2837099B1 (en)
ZA (1) ZA200407316B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969087A (en) * 1974-08-07 1976-07-13 Ajinomoto Co., Ltd. Gels of nonpolar liquids with N-acyl amino acids and derivatives thereof as gelling agents
US5968542A (en) * 1995-06-07 1999-10-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
BE1011899A6 (en) * 1998-04-30 2000-02-01 Ucb Sa PHARMACEUTICAL USE gelling.
FR2794998B1 (en) * 1999-06-21 2001-07-27 Oreal ORGANOGELS AND THEIR USES, ESPECIALLY COSMETICS

Also Published As

Publication number Publication date
ZA200407316B (en) 2006-02-22
ES2607980T3 (en) 2017-04-05
FR2837099A1 (en) 2003-09-19

Similar Documents

Publication Publication Date Title
DK1545662T3 (en) drug delivery
DK1517697T3 (en) Acidic insulin preparations with improved stability
DK1406633T3 (en) Improved drug delivery in transdermal systems
AU2003291103A8 (en) Pharmaceutical composition
EP1425019A4 (en) Pharmaceutical composition
EP1548121A4 (en) Novel physiologically active substances
HK1076743A1 (en) Orodispersible pharmaceutical composition comprising perindopril
AU2003250372A8 (en) Pharmaceutical composition
GB2391809B (en) Pharmaceutical composition comprising honey
ZA200506750B (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluroanilino) phenylacetic acid
PT1558263E (en) PROLONGED LIBERATION PHARMACEUTICAL COMPOSITION
DK1474152T3 (en) Orodispersible pharmaceutical composition comprising ivabradine
PL361364A1 (en) Peptide and pharmaceutical composition as well as their therapeutic applications
FR2837099B1 (en) COMPOSITION WITH GELIFYING PROPERTIES FOR PROLONGED DELIVERY OF BIO-ACTIVE SUBSTANCES
GB0317877D0 (en) Pharmaceutical combinations and formulations with improved stability
ATE456573T1 (en) NMB0928 PROTEIN AND ITS USE IN PHARMACEUTICAL FORMULATIONS
GB0327006D0 (en) Drug compositon and therapeutics
GB0327814D0 (en) Aerosolisable composition and delivery system
GB0406014D0 (en) Pharmaceutical composition and use
AU2003232176A8 (en) Protein c variants with altered properties
ATE444305T1 (en) NMB1125 PROTEIN AND ITS USE IN PHARMACEUTICAL FORMULATIONS
GB0217703D0 (en) Pharmaceutical composition
DOP2002000508A (en) PHARMACEUTICAL COMPOSITION
GB0208324D0 (en) Administration of beneficial substances
SE0203563D0 (en) Natural ingredients with analgesic properties

Legal Events

Date Code Title Description
TQ Partial transmission of property
GC Lien (pledge) constituted

Effective date: 20140519

PLFP Fee payment

Year of fee payment: 14

GC Lien (pledge) constituted

Effective date: 20160120

PLFP Fee payment

Year of fee payment: 15

RG Lien (pledge) cancelled

Effective date: 20160226

PLFP Fee payment

Year of fee payment: 16

RG Lien (pledge) cancelled

Effective date: 20170418

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 19

ST Notification of lapse

Effective date: 20211105